VASCULAR BIOGENICS LTD (VBLT) Stock Analyst Earnings Estimates
NASDAQ:VBLT - Nasdaq - IL0011327454 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 920K 64.29% | 768K -16.52% | 658K -14.32% | 1.962M 198.18% | 1.962M | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBITDA YoY % growth | -23.29M -23.49% | -28.74M -23.40% | -31.795M -10.63% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -24.48M -21.91% | -29.996M -22.53% | -32.853M -9.52% | -11.69M 64.42% | -18.278M -56.36% | -31.73M -73.59% | -76.493M -141.07% | -80.313M -4.99% | -84.655M -5.41% | -88.796M -4.89% | -92.479M -4.15% | |
| Operating Margin | -2,660.87% | -3,905.73% | -4,992.86% | -595.83% | -931.62% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -0.56 -1.82% | -0.45 19.64% | N/A -17.87% | -0.61 -15.38% | -0.75 -23.33% | -0.83 -9.46% | -0.88 -6.17% | -0.93 -5.81% | -0.99 -6.59% | -1.05 -6.19% | -1.10 -4.85% |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.15 -27.50% | -0.16 -14.29% |
| Revenue Q2Q % growth | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.12 -33.33% | -0.11 | -0.01 | -6.95% |
| Q2 2022 Q2Q % growth | -0.12 | -0.11 | -0.01 | -12.04% |
| Q1 2022 Q2Q % growth | -0.13 -8.33% | -0.11 | -0.02 | -18.01% |
| Q4 2021 Q2Q % growth | -0.12 20.00% | -0.09 | -0.03 | -34.45% |
| Q3 2021 Q2Q % growth | -0.09 25.00% | -0.11 | 0.02 | 17.92% |
| Q2 2021 Q2Q % growth | -0.12 14.29% | -0.11 | -0.01 | -9.44% |
| Q1 2021 Q2Q % growth | -0.12 20.00% | -0.13 | 0.01 | 9.50% |
| Q4 2020 Q2Q % growth | -0.15 6.25% | -0.14 | -0.01 | -5.04% |
| Q3 2020 Q2Q % growth | -0.12 14.29% | -0.14 | 0.02 | 11.94% |
| Q2 2020 Q2Q % growth | -0.14 -7.69% | -0.14 | 0.00 | 0.54% |
| Q1 2020 Q2Q % growth | -0.15 -25.00% | -0.17 | 0.02 | 11.20% |
| Q4 2019 Q2Q % growth | -0.16 | -0.14 | -0.02 | -17.06% |
| Q3 2019 Q2Q % growth | -0.14 | -0.15 | 0.01 | 3.68% |
| Q2 2019 Q2Q % growth | -0.13 | -0.14 | 0.01 | 5.59% |
| Q1 2019 Q2Q % growth | -0.12 | -0.12 | 0.00 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 481K 141.71% | 204K | 277K | 135.78% |
| Q2 2022 Q2Q % growth | 64K -65.96% | 1.428M | -1.364M | -95.52% |
| Q1 2022 Q2Q % growth | 113K -38.92% | 204K | -91K | -44.61% |
| Q4 2021 Q2Q % growth | 196K -6.67% | 200.94K | -4.94K | -2.46% |
| Q3 2021 Q2Q % growth | 199K 4.74% | 153K | 46K | 30.07% |
| Q2 2021 Q2Q % growth | 188K 17.50% | 331.5K | -143.5K | -43.29% |
| Q1 2021 Q2Q % growth | 185K -50.00% | 204K | -19K | -9.31% |
| Q4 2020 Q2Q % growth | 210K 61.54% | 229.5K | -19.5K | -8.50% |
| Q3 2020 Q2Q % growth | 190K 137.50% | 169.932K | 20.068K | 11.81% |
| Q2 2020 Q2Q % growth | 160K 14.29% | 155.55K | 4.45K | 2.86% |
| Q1 2020 Q2Q % growth | 370K 68.18% | 165.24K | 204.76K | 123.92% |
| Q4 2019 Q2Q % growth | 130K | 116.28K | 13.72K | 11.80% |
| Q3 2019 Q2Q % growth | 80K | 123.165K | -43.165K | -35.05% |
| Q2 2019 Q2Q % growth | 140K | 127.5K | 12.5K | 9.80% |
| Q1 2019 Q2Q % growth | 220K | 782.003K | -562.003K | -71.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |